Genomic Complexity Linked With Poor Outcomes in DLBCL

August 16th 2021, 9:20pm


A new report could eventually help investigators better understand which patients with diffuse large B-cell lymphoma (DLBCL) are most likely to respond to certain therapies.

High-Dose Methotrexate Effective in Preventing Isolated CNS Relapse in Diffuse Large B-Cell Lymphoma

August 13th 2021, 6:30pm


Risk of isolated central nervous system (CNS) involvement was found to be significantly lower in patients with diffuse large B-cell lymphoma who received high-dose methotrexate vs RCHOP chemotherapy, although risk of concomitant CNS-systemic relapse rates were similar between both groups.

Meta-Analysis Finds CIT Regimens Associated With Improved Survival, Safety Outcomes in NSCLC

August 11th 2021, 6:30pm


Due to the lack of head-to-head trials comparing chemoimmunotherapy regimens with chemotherapy alone as first-line treatment for non-small cell lung cancer, researchers conducted a network meta-analysis of 17 randomized controlled trials of patients with the cancer.

An Inside Look at Disparities in Lung Cancer Care for At-Risk Populations

August 1st 2021, 1:00pm


On World Lung Cancer Day, we explore current guidelines for lung cancer screening in the United States, implications of the COVID-19 pandemic, and disparities in mortality and access to care by race and socioeconomic status.

Long-term Survival Trends Among AYAs With the Highest Mortality Cancer Types

July 30th 2021, 9:32pm


Long-term survival trends among adolescents and young adults (AYAs) with the cancer types with the highest mortality highlight areas where additional research is needed.

Addressing Financial Toxicity With Patients and Health Systems

July 23rd 2021, 1:30pm


Speakers at the Advanced Topics for Oncology Pharmacy Professionals Summit discussed financial toxicity in health care, how it particularly impacts patients with cancer, and how to address the issue with patients and the health system.

CMS Seeks Changes to Radiation Oncology Model; ASTRO Responds

July 20th 2021, 9:04pm


Due to unprecedented disruption and missed screenings during the pandemic, efforts to implement a 5-year performance period under the Radiation Oncology Model were extended twice.

Dr Todd Schlesinger: Surgical Decisions for Skin Cancer Are Multimodal

July 16th 2021, 6:00pm


The characteristics of the tumor and the presence of surgical fatigue can help determine patients’ candidacy for skin cancer surgery, explained Todd Schlesinger, MD, FAAD, director, Dermatology and Laser Center of Charleston and Clinical Research Center of the Carolinas.

ASCO, COA Release Updated Standards for Oncology Medical Home

July 13th 2021, 6:00pm


The new standards come as community oncology practices await word on the future of the oncology care model, which will expire in 2022.

Obesity, Disparities, and Treatment Advancements Shape US Cancer Trends

July 8th 2021, 10:00am


New data underscore how obesity, racial disparities and recent treatment advancements have impacted cancer mortality and incidence rates.